In this issue of Cell Reports, Almendro et al. report one of the first comprehensive studies on the intratumor heterogeneity of cell phenotypes and genotypes before and after chemotherapy in breast cancer. These data challenge the concept of genetic population bottlenecks and suggest that cellular phenotypes play an important role in developing resistance to therapy
International audienceAccording to the clonal model and Darwinian evolution, cancer cell evolves thr...
Phenotypic heterogeneity in cancers is associated with invasive progression and drug resistance. Thi...
International audiencePhenotype heterogeneity in cancer cell populations, be it of genetic, epigenet...
In this issue of Cell Reports, Almendro et al. report one of the first comprehensive studies on the ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Intra-tumor heterogeneity of cancer cells hampers the design of effective therapies and yet it is po...
Since the pioneering studies of Heppner and co-workers on mouse mammary cancer, the presence of hete...
The heterogeneity of breast cancer plays a major role in drug response and resistance and has been e...
Comparison of intratumor genetic heterogeneity in cancer at diagnosis and relapse suggests that chem...
Heterogeneity in tumors is recognized as a key contributor to drug resistance and spread of advanc...
Metastatic disease is themain cause of cancer-relatedmortality due to almost universal therapeutic r...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
Metastatic disease is the main cause of cancer-related mortality due to almost universal therapeutic...
International audienceAccording to the clonal model and Darwinian evolution, cancer cell evolves thr...
Phenotypic heterogeneity in cancers is associated with invasive progression and drug resistance. Thi...
International audiencePhenotype heterogeneity in cancer cell populations, be it of genetic, epigenet...
In this issue of Cell Reports, Almendro et al. report one of the first comprehensive studies on the ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Cancer therapy exerts a strong selection pressure that shapes tumor evolution, yet our knowledge of ...
Intra-tumor heterogeneity of cancer cells hampers the design of effective therapies and yet it is po...
Since the pioneering studies of Heppner and co-workers on mouse mammary cancer, the presence of hete...
The heterogeneity of breast cancer plays a major role in drug response and resistance and has been e...
Comparison of intratumor genetic heterogeneity in cancer at diagnosis and relapse suggests that chem...
Heterogeneity in tumors is recognized as a key contributor to drug resistance and spread of advanc...
Metastatic disease is themain cause of cancer-relatedmortality due to almost universal therapeutic r...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
Metastatic disease is the main cause of cancer-related mortality due to almost universal therapeutic...
International audienceAccording to the clonal model and Darwinian evolution, cancer cell evolves thr...
Phenotypic heterogeneity in cancers is associated with invasive progression and drug resistance. Thi...
International audiencePhenotype heterogeneity in cancer cell populations, be it of genetic, epigenet...